Buprenorphine and Naloxone 2 mg/1

Buprenorphine Hydrochloride and Naloxone Hydrochloride, the active ingredients in Buprenorphine and Naloxone, is a partial opioid agonist and opioid antagonist combination presented as a 2 mg/1 mg tablet for sublingual use. It is used to treat opioid dependence and opioid use disorder as part of a comprehensive treatment plan. GNH USA supplies Buprenorphine and Naloxone as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

GNH USA is a trusted supplier of high-quality pharmaceuticals, ensuring that Buprenorphine and Naloxone is available to healthcare providers and patients who need it.

Buprenorphine and Naloxone is used to treat opioid dependence and opioid use disorder. It helps to manage withdrawal symptoms and cravings associated with opioid addiction.

- Opioid dependence: Helps manage withdrawal symptoms and cravings. - Opioid use disorder: Part of a comprehensive treatment plan to reduce opioid use. - Maintenance therapy for opioid addiction: Used to maintain abstinence from opioids and prevent relapse.

Buprenorphine and Naloxone can cause various side effects, ranging from common to serious.

Common Side Effects: - Nausea: Feeling sick to your stomach. - Vomiting: Forceful expulsion of stomach contents. - Headache: Pain in the head. - Constipation: Difficulty passing stools. - Sweating: Excessive perspiration. - Insomnia: Difficulty falling or staying asleep.

Serious or Rare Side Effects: - Respiratory depression: Slow or shallow breathing. - Allergic reactions: Severe allergic responses, including rash, itching, and swelling. - Liver toxicity: Damage to the liver. - Depression: Feelings of extreme sadness or hopelessness. - Seizures: Sudden, uncontrolled electrical disturbances in the brain.

Buprenorphine and Naloxone should be used with caution and under medical supervision. Important precautions include:

- Pregnancy: Consult your doctor before use during pregnancy. - Breastfeeding: Discuss the risks and benefits with your healthcare provider. - Respiratory issues: Use with caution in patients with respiratory problems. - Hepatic impairment: Adjust dosage as needed for patients with liver issues. - Drug interactions: Avoid concurrent use with other opioids or CNS depressants. - Storage: Store below 25°C: keep in the original pack, protect from moisture.

Buprenorphine and Naloxone can interact with other medications, leading to potential complications.

Major Interactions (Avoid): - Other opioids: Can cause severe respiratory depression. - Benzodiazepines: Increased risk of sedation and respiratory depression. - Alcohol: Enhanced sedative effects and respiratory depression.

Moderate Interactions (Monitor Closely): - Antidepressants: May increase the risk of serotonin syndrome. - Antipsychotics: Can enhance sedative effects. - Antihistamines: May increase drowsiness and sedation.